Novartis AG
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
Last updated:
Abstract:
The present invention relates to anti-polyomavirus antibodies, antibody fragments, and their uses for the prevention and treatment of BK or JC virus infection and associated diseases.
Status:
Application
Type:
Utility
Filling date:
28 Nov 2018
Issue date:
10 Dec 2020